Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Alif, N.
Hess, K.
Straczek, J.
Sebbar, S.
Belahsen, Y.
Mouane, N.
Abkari, A.
Nabet, P.
and
Gelot, M.A.
2000.
Mucopolysaccharidose de type I au Maroc: manifestations cliniques et profil génétique.
Archives de Pédiatrie,
Vol. 7,
Issue. 6,
p.
597.
Terlato, Nancy J.
and
Cox, Gerald. F.
2003.
Can mucopolysaccharidosis type I disease severity be predicted based on a patient’s genotype? A comprehensive review of the literature.
Genetics in Medicine,
Vol. 5,
Issue. 4,
p.
286.
2005.
Atlas of Metabolic Diseases Second edition.
p.
512.
Laradi, S.
Tukel, T.
Erazo, M.
Shabbeer, J.
Chkioua, L.
Khedhiri, S.
Ferchichi, S.
Chaabouni, M.
Miled, A.
and
Desnick, R. J.
2005.
Mucopolysaccharidosis I: α‐L‐Iduronidase mutations in three Tunisian families.
Journal of Inherited Metabolic Disease,
Vol. 28,
Issue. 6,
p.
1019.
Vazna, Alzbeta
Beesley, Clare
Berna, Linda
Stolnaja, Larisa
Myskova, Helena
Bouckova, Michaela
Vlaskova, Hana
Poupetova, Helena
Zeman, Jiri
Magner, Martin
Hlavata, Anna
Winchester, Bryan
Hrebicek, Martin
and
Dvorakova, Lenka
2009.
Mucopolysaccharidosis type I in 21 Czech and Slovak patients: Mutation analysis suggests a functional importance of C‐terminus of the IDUA protein.
American Journal of Medical Genetics Part A,
Vol. 149A,
Issue. 5,
p.
965.
Khedhiri, S.
Chkioua, L.
Bouzidi, H.
Dandana, A.
Ben Turkia, H.
Miled, A.
and
Laradi, S.
2009.
Mucopolysaccharidoses type I and IVA: Clinical features and consanguinity in Tunisia.
Pathologie Biologie,
Vol. 57,
Issue. 5,
p.
392.
Chkioua, L.
Ferchichi, S.
Khedhiri, S.
Jaidane, Z.
Chahed, H.
Wesleti, S.
Froissart, R.
Maire, I.
Laradi, S.
and
Miled, A.
2010.
Prenatal diagnosis of the Hurler syndrome by microsatellite markers analysis.
Immuno-analyse & Biologie Spécialisée,
Vol. 25,
Issue. 1,
p.
38.
Furukawa, Yutaka
Hamaguchi, Ayumi
Nozaki, Ichiro
Iizuka, Takashi
Sasagawa, Takeshi
Shima, Yosuke
Demura, Satoru
Murakami, Hideki
Kawahara, Norio
Okuyama, Torayuki
Iwasa, Kazuo
and
Yamada, Masahito
2011.
Cervical pachymeningeal hypertrophy as the initial and cardinal manifestation of mucopolysaccharidosis type I in monozygotic twins with a novel mutation in the alpha-l-iduronidase gene.
Journal of the Neurological Sciences,
Vol. 302,
Issue. 1-2,
p.
121.
Chkioua, Latifa
Khedhiri, Souhir
Ben Turkia, Hadhami
Chahed, Henda
Ferchichi, Salima
Ben Dridi, Marie Françoise
Laradi, Sandrine
and
Miled, Abdelhedi
2011.
Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population.
Diagnostic Pathology,
Vol. 6,
Issue. 1,
Chkioua, Latifa
Khedhiri, Souhir
Kassab, Asma
Bibi, Amina
Ferchichi, Salima
Froissart, Roseline
Vianey-Saban, Christine
Laradi, Sandrine
and
Miled, Abdelhedi
2011.
Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms.
Diagnostic Pathology,
Vol. 6,
Issue. 1,
Chkioua, Latifa
Khedhiri, Souhir
Turkia, Hadhami Ben
Tcheng, Rémy
Froissart, Roseline
Chahed, Henda
Ferchichi, Salima
Ben Dridi, Marie Françoise
Vianey-Saban, Christine
Laradi, Sandrine
and
Miled, Abdelhedi
2011.
Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients.
Diagnostic Pathology,
Vol. 6,
Issue. 1,
Romdhane, Lilia
Kefi, Rym
Azaiez, Hela
Halim, Nizar Ben
Dellagi, Koussay
and
Abdelhak, Sonia
2012.
Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East.
Orphanet Journal of Rare Diseases,
Vol. 7,
Issue. 1,
Bie, Haiying
Yin, Jiang
He, Xu
Kermode, Allison R
Goddard-Borger, Ethan D
Withers, Stephen G
and
James, Michael N G
2013.
Insights into mucopolysaccharidosis I from the structure and action of α-L-iduronidase.
Nature Chemical Biology,
Vol. 9,
Issue. 11,
p.
739.
Tebani, Abdellah
Zanoutene-Cheriet, Lahouaria
Adjtoutah, Zoubir
Abily-Donval, Lenaig
Brasse-Lagnel, Carole
Laquerrière, Annie
Marret, Stephane
Chalabi Benabdellah, Abla
and
Bekri, Soumeya
2016.
Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series.
International Journal of Molecular Sciences,
Vol. 17,
Issue. 5,
p.
743.
Poletto, E.
Pasqualim, G.
Giugliani, R.
Matte, U.
and
Baldo, G.
2018.
Worldwide distribution of common IDUA pathogenic variants.
Clinical Genetics,
Vol. 94,
Issue. 1,
p.
95.
Romdhane, Lilia
Messaoud, Olfa
Kefi, Rym
Tiar, Afaf
Amouri, Ahlem
Mokni, Mourad
Tebib, Neji
Zghal, Mohamed
Barakat, Abdelhamid
Houmeida, Ahmed
Bozguiya, Mariem
Othman, Mohamed
El-Kamah, Ghada
and
Abdelhak, Sonia
2019.
The Genetics of African Populations in Health and Disease.
p.
233.
Kamranjam, Mana
and
Alaei, Mohammadreza
2019.
Mutation Analysis of the IDUA Gene in Iranian Patients with Mucopolysaccharidosis Type 1: Identification of Four Novel Mutations.
Genetic Testing and Molecular Biomarkers,
Vol. 23,
Issue. 8,
p.
515.
Zahoor, Muhammad Yasir
Cheema, Huma Arshad
Ijaz, Sadaqat
Anjum, Muhammad Nadeem
Ramzan, Khushnooda
and
Bhinder, Munir Ahmad
2019.
Mapping of IDUA gene variants in Pakistani patients with mucopolysaccharidosis type 1.
Journal of Pediatric Endocrinology and Metabolism,
Vol. 32,
Issue. 11,
p.
1221.
Celik, Betul
Tomatsu, Saori C.
Tomatsu, Shunji
and
Khan, Shaukat A.
2021.
Epidemiology of Mucopolysaccharidoses Update.
Diagnostics,
Vol. 11,
Issue. 2,
p.
273.
De Ponti, Giada
Donsante, Samantha
Frigeni, Marta
Pievani, Alice
Corsi, Alessandro
Bernardo, Maria Ester
Riminucci, Mara
and
Serafini, Marta
2022.
MPSI Manifestations and Treatment Outcome: Skeletal Focus.
International Journal of Molecular Sciences,
Vol. 23,
Issue. 19,
p.
11168.